Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

Experts: Pvt sector participation key to healthcare sector development

Private investors will not be able to play the expected role in this sector unless the complexity of obtaining and renewing licenses is reduced

Update : 25 Nov 2025, 06:50 PM

Entrepreneurs and experts emphasized timely policies and simplified licensing processes for the sustainable development of the country's healthcare, medical equipment and pharmaceutical industries.

According to them, private investors will not be able to play the expected role in this sector unless the complexity of obtaining and renewing licenses is reduced.

These views were expressed at a seminar titled "Private Sector Participation in Healthcare Sector Development: Opportunities and Challenges" organized by FBCCI in the capital on Tuesday.

FBCCI Administrator Md Abdur Rahim Khan presided over the program.

Health Service Division Secretary Md. Saidur Rahman was the chief guest.

The seminar's keynote address was presented by Dr Syed Abdul Hamid, Professor of the Institute of Health Economics, University of Dhaka.

He said that Bangladesh is still lagging behind in the production of raw materials or APIs, which is a big threat to the pharmaceutical industry. Besides, the complicated licensing process is hampering the progress of the industry.

Major General (Retd) Md. Mostafizur Rahman, CEO of the Bangladesh Pharmaceutical Industry Association, said that an entrepreneur has to obtain licenses from 47 organizations to set up an API industry, which is one of the reasons for discouraging investment.

Md Abdur Razzak, managing director of JMI Group, said that a modern and effective policy for entrepreneurs in this sector is the need of the hour.

Md Akramul Islam, senior director of Brac Health Program, said that the private sector cannot be encouraged to invest in healthcare, medical equipment and pharmaceutical industries unless the licensing-related complications are reduced.

Md Asraf Hossain, director of the Directorate General of Drug Administration, said that the department is always striving to fulfill its responsibilities properly. Even if it takes some time to scrutinize and select an organization's application, there is no deliberate delay.

Speaking as chief guest, Md Saidur Rahman said that initiatives have already been taken to make licensing of the pharmaceutical industry easier and faster. The issue of extending the license period to at least three years is under consideration.

Gazi AKM Fazlul Haque, DG of the Bangladesh Investment Development Authority (Bida), said that Bida has formulated a draft of separate policies for the medical equipment industry. It will be implemented with the opinion of the DGDA.

Top Brokers